Ariadne Genomics and Infocom Collaborate
News Nov 02, 2005
Ariadne Genomics will integrate Auto Net Finder with its PathwayStudio® Central client-server pathway analysis software. Integration of Auto Net Finder with PathwayStudio Central adds new means to the analysis of microarray and proteomics data.
"There is a common problem with microarray data analysis. Usually the data has too many variables, genes, and too much similar-expression data, which creates difficulties in interpretation of the data in terms of molecular networks, distinguishing between direct and indirect correlation," said Kikuo Ohgaki, General Manager at Infocom CO.
"By utilizing a combination of network analysis tools, Auto Net Finder can predict networks more accurately and far more efficiently estimate inter-cluster relationships."
The addition of AutoNet Finder extends the use of Ariadne Genomics' PathwayStudio Central. Using these integrated products, scientists can infer regulatory networks from gene expression data and validate them through comparison with ResNet™ database of functional relationships compiled from literature, a part of PathwayStudio Central.
"Understanding the molecular mechanisms behind gene or protein expression changes is one of the most pressing tasks of today's systems biology in light of the huge amounts of microarray data that are easily available." commented Ilya Mazo, President at Ariadne Genomics.
"We plan to provide a collection of inference algorithms aimed at the reconstruction of regulatory networks from microarray data. For our clients, it will simplify the analysis of complex data sets and help to generate new insights into the mechanisms of cell regulation."
Auto Net Finder was developed through two-year collaboration between Infocom and Dr. Katsuhisa Horimoto at the Human Genome Center, Institute of Medical Science, University of Tokyo. The software will be available as a network-inferring module for Ariadne Genomics Pathway analysis products for an additional fee.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE